SGEN - Seattle Genetics Inc.

$9.19 0.39 | 4.43%
Today's Range: 8.80 - 9.26
SGEN Avg. Daily Volume: 1,354,525
12/16/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 9.19
52 Week High 14.94
52 Week Low 7.00
Avg. Daily Vol. (Mil) 0.74
Beta (3 year) 1.13
Share Related Items
Mkt Cap (Mil) 923.89
Shares Out (Mil) 100.53
Float (Mil) 85.96
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.50
Current Ratio 5.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 22.95
Price/Book 4.29
Price/Cash Flow -9.70
Per Share Data
Earnings -1.19
Sales 0.40
Book Value 2.14
Cash Flow -0.95
Business Summary
A biotechnology company, which is focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
General Information
21823 30th Drive SE
Bothell, WA 98021
www.seattlegenetics.com
Industry : Drugs
Sector: Health Care
Employees: 261
CEO: Dr. Clay B. Siegall, Ph.
Short Interest
Current Month (Mil) 6.21
Previous Month (Mil) 5.92
Short Interest Ratio (Days) 11.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -30.70
Return on Investments -46.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Latest SGEN Headlines

Brokerage Partners

TheStreet Premium Services

All Services